This website uses cookies to enhance the user experience.
||
G

GENTIAN AS979 819 234

Limited company
Bjørnåsveien 5 1596 MOSS, Norge

GENTIAN AS

Operating
Identifisere og inn-lisensiere unik teknologi innen farmasi for å drive forskning, utvikling, produksjon og salg/markedsføring. Selskapet kan også gjøre seg interessert i andre områder som faller naturlig inn i forretningskonsepter.
Forskning og utvikling av diagnostiske tester rettet mot større sykdomsområder som infeksjon, hjerte og karsykdommer, samt kreft.

Links

Organization

CEO
Chairman of the board
Years since formation
28 years
since May 5, 1998
Type
Limited company
VAT registered
Yes
Number of employees
53

Ownership

Number of shares and share classes
20,000,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2025
148,296,607
NOK
Annual total result 2025
32,398,455
NOK
Total equity 2025
162,725,311
NOK
Last update: Jun 10, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-

Others

NameRoleShares
B
BDO AS
Auditor-

Top 10 individual shareholders

NameRoleShares
-
13.7 %
indirectly
-
7.82 %
indirectly
-
4.21 %
indirectly
-
3.75 %
indirectly
-
3.71 %
indirectly
-
2.64 %
indirectly
-
2.64 %
indirectly
-
1.93 %
indirectly
-
1.38 %
indirectly
-
1.26 %
indirectly
Last update: May 15, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
G
GENTIAN DIAGNOSTICS ASA
Ordinary shares
20,000,000
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 2,245,000
    Operating profit 2025: NOK -14,042,728
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
148,296,607
138,044,747
118,224,537
96,421,779
85,257,579
Annual Total Result
32,398,455
60,333,027
-1,772,208
-13,089,728
-11,390,103
Total assets
214,231,519
179,418,295
111,011,472
124,502,834
113,541,415
Total liabilities
51,506,208
50,451,264
103,960,476
116,124,293
93,684,130
Total equity
162,725,311
128,967,030
7,050,996
8,378,542
19,857,285

P&L

Year20252024202320222021
Total operating income
148,296,607
138,044,747
118,224,537
96,421,779
85,257,579
Total operating costs
101,960,344
99,517,339
116,361,709
105,620,895
94,189,719
Operating result
46,336,263
38,527,407
1,862,827
-9,199,116
-8,932,140
Financial income/costs
-1,527,813
-3,423,577
-3,635,035
-3,890,612
-2,457,963
Profit before tax
44,808,450
35,103,830
-1,772,208
-13,089,728
-11,390,103
Total tax & extraordinary income/cost
12,409,995
-25,229,197
0
0
0
Annual Total Result
32,398,455
60,333,027
-1,772,208
-13,089,728
-11,390,103

Balance overview

Year20252024202320222021
Total fixed assets
89,162,564
78,057,591
48,339,902
55,867,282
51,862,075
Total current assets
125,068,955
101,360,704
62,671,570
68,635,552
61,679,341
Total assets
214,231,519
179,418,295
111,011,472
124,502,834
113,541,415
Short term debt
23,705,467
26,586,751
18,242,608
18,463,500
15,049,813
Long term debt
27,800,740
23,864,514
85,717,869
97,660,792
78,634,317
Total liabilities
51,506,208
50,451,264
103,960,476
116,124,293
93,684,130
Contributed capital
75,000,000
75,000,000
15,000,000
15,000,000
18,898,693
Retained earnings
87,725,311
53,967,030
-7,949,004
-6,621,458
958,592
Total equity
162,725,311
128,967,030
7,050,996
8,378,542
19,857,285
Total equity and liabilities
214,231,519
179,418,295
111,011,472
124,502,834
113,541,415

Classification

21st company classification
BETA
Industrial large enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises